Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Immunological Effects of Iron Supplementation in HHT Disease — Stella

Home/Hereditary Haemorrhagic Telangiectasia/Immunological Effects of Iron Supplementation in HHT Disease

View on ClinicalTrials.gov

Recruiting

Back to Hereditary Haemorrhagic Telangiectasia trials

Immunological Effects of Iron Supplementation in HHT Disease

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

Hôpital Femme-Mère-Enfant, Bron, Rhone

Key details

Sponsor

Hospices Civils de Lyon

Enrollment target

~155 participants

Started

September 2025

Primary completion

December 2028

Age range

18 Years – 99 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.